Paul Gurbel to Hemorrhage
This is a "connection" page, showing publications Paul Gurbel has written about Hemorrhage.
Connection Strength
0.350
-
Prediction of Ischemic and Bleeding Events Using the Dual Antiplatelet Therapy Score in an Unrestricted Percutaneous Coronary Intervention Population. Circ Cardiovasc Interv. 2018 10; 11(10):e006853.
Score: 0.077
-
Peri-Procedural Platelet Reactivity in Percutaneous Coronary Intervention. Thromb Haemost. 2018 Jul; 118(7):1131-1140.
Score: 0.075
-
Evaluation of potential antiplatelet effects of CSL112 (Apolipoprotein A-I [Human]) in patients with atherosclerosis: results from a phase 2a study. J Thromb Thrombolysis. 2018 May; 45(4):469-476.
Score: 0.075
-
Determination of non-Vitamin K oral anticoagulant (NOAC) effects using a new-generation thrombelastography TEG 6s system. J Thromb Thrombolysis. 2017 May; 43(4):437-445.
Score: 0.070
-
Should Antithrombotic Treatment Strategies in East Asians Differ from Caucasians? Curr Vasc Pharmacol. 2018; 16(5):459-476.
Score: 0.018
-
Advocating cardiovascular precision medicine with P2Y12 receptor inhibitors. Eur Heart J Cardiovasc Pharmacother. 2017 10 01; 3(4):221-234.
Score: 0.018
-
Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry Study. JACC Cardiovasc Interv. 2017 08 28; 10(16):1607-1617.
Score: 0.018